
Pharmakon Asia is one of the best pharma magazine Europe. Pharmakon Asia is one of the leading website and magazine covering the need of global Pharmaceutical Industry . Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmakonasia.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry. Pharmakon Asia aims of providing fast and informative articles to its readers and subscribers.
Pharmakon, in philosophy and critical theory, is a composite of three meanings: remedy, poison, and scapegoat.[1] The first and second senses refer to the everyday meaning of pharmacology (and to its sub-field, toxicology), deriving from the Greek source term φάρμακον (phármakon), denoting any drug, while the third sense refers to the pharmakos ritual of human sacrifice. A further sub-sense of pharmakon as remedy which is of interest to some current authors is given by the Liddell-Scott-Jones Greek–English Lexicon as "a means of producing something"



The launch of the much-awaited healthcare programme – “Ayushman Bharat” is changing the dynamics of the healthcare sector in India as a majority of the players and MNC’s are keen to participate in this programme.
The flagship programme is coined as the world’s largest government-aided that aims to benefit around 50 core citizens.
With companies like Pfizer, GlaxoSmithKline Pharma and Abbott proposing to launch a ‘second brand’ that are low-priced than the original products, this move can bring huge relief for the economically backward families.
Sources believe that by introducing these second-brands into the Ayushman health scheme would definitely be a gigantic step in eradicating illnesses from India.
If implemented, this can erase the debt trap faced by the poor families in case of medical urgencies.At a recently concluded interaction between the US India Business Council and the National Health Agency (NHA), USIBC has put forth some strategic ideas and suggestion that includes creating “policy provisions” that ultimately exempts the products from price referencing and hence lowering the costs of these drugs.
The other suggestion was to conduct screening camps to identify the patients that would help the government to prepare a steady database.

The global prefilled syringes market was valued at $3,905.1 million in 2014, and it is expected to grow with a CAGR of 12.9% during 2015 - 2020.The global prefilled syringes market is growing, due to increasing demand for vaccines, growing geriatric population, increasing prevalence of chronic and lifestyle associated diseases, and increasing healthcare expenditure.
In addition, the technological advancement in prefilled syringes, regulations regarding needlestick injuries increases popularity of prefilled syringes, increasing injectable drugs pipeline, and increasing demand for point-of-care administration are also driving the growth of the global market.
Request to sample: https://www.psmarketresearch.com/market-analysis/prefilled-syringes-market/report-sampleHowever, strict regulatory requirements, recall of prefilled syringes, interaction of prefilled syringe with drugs, alternative drug delivery methods, and manufacturing complexity and high cost of prefilled syringe act as hindrance in the growth of the global market of prefilled syringes.
The increasing combination therapies and customized prefilled syringes are the latest trends observed in this market.Send Enquiry: https://www.psmarketresearch.com/send-enquiry?enquiry-url=prefilled-syringes-marketIn 2014, Europe dominated the global market of prefilled syringes, among all the regions of the global market in terms of volume; whereas, the Asia-Pacific market is expected to witness the fastest growth, with a CAGR of 16.0% during the forecast period in terms of value.The key companies operating in the global prefilled syringes market include Becton, Dickinson and Company, SCHOTT AG, Gerresheimer AG, Unilife Corporation, Nipro Corporation, Baxter International Inc., West Pharmaceutical Services Inc., Ypsomed Holding AG, Stevanato Group S.p.a., Vetter Pharma-Fretigung GmbH & Co., and Bespak Europe Ltd.About P IntelligenceP Intelligence, a brand of P Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world.
Providing the plinth of market intelligence, P as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.Contact: P IntelligenceToll-free: +1-888-778-7886 (USA/Canada) International: +1-347-960-6455Email: enquiry@psmarketresearch.comWeb: https://www.psmarketresearch.comConnect with us: LinkedIn | Twitter | Google + | Facebook

The global food allergy diagnostics & therapeutics market size is expected to reach USD 4.71 billion by 2026, exhibiting a CAGR of 7.4%.
The market is expected to grow in the coming years owing to increasing incidence of food allergies coupled with rising demand for products for management of these conditions.Get Exclusive Free Sample Copy Of This Report @ https://www.radiantinsights.com/research/food-allergy-diagnostics-and-therapeutics-market/request-sampleThere are more than 160 foods that can lead to allergic reactions; however, only 8 most common allergens have been identified by the FDA.
These include eggs, milk, peanuts, soy, tree nuts, wheat, shellfish, and fish.
Some of the other allergens are corn, meat, gelatin, seeds, spices, and fruits & vegetables.
Based on Food Allergy Research and Education (FARE) 2016 data, around 15 million people in the U.S. have food allergy.
Ingestion of any of the common allergens might lead to anaphylaxis, a life-threatening allergic reaction, which might further result in anaphylactic shock.

